MEDAVAIL HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | 0.00% |
|
0.00% | -100.00% |
| Feb. 15 | MedAvail Holdings, Inc.(OTCPK:MDVL.Q) dropped from S&P TMI Index | CI |
| Feb. 15 | MedAvail Holdings, Inc.(OTCPK:MDVL.Q) dropped from S&P TMI Index | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 476.6 | 45.99 | 24 |
| Enterprise Value (EV) 1 | 422.2 | 38.55 | 19.63 |
| P/E ratio | -3.21 x | -1.04 x | -0.41 x |
| Yield | - | - | - |
| Capitalization / Revenue | 34.1 x | 2.08 x | 0.56 x |
| EV / Revenue | 30.2 x | 1.74 x | 0.46 x |
| EV / EBITDA | -22.2 x | -0.94 x | -0.47 x |
| EV / FCF | -27,394,176 x | -1,447,158 x | -628,757 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 7.84 x | 2.42 x | 1.17 x |
| Nbr of stocks (in thousands) | 633 | 657 | 1,601 |
| Reference price 2 | 752.5 | 70.00 | 14.99 |
| Announcement Date | 3/31/21 | 3/29/22 | 4/14/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net sales 1 | 4.665 | 3.771 | 13.97 | 22.13 | 43.11 |
| EBITDA 1 | -14.62 | -19.06 | -19.01 | -40.93 | -41.77 |
| EBIT 1 | -16.34 | -20.71 | -20.81 | -43.51 | -46.42 |
| Operating Margin | -350.23% | -549.11% | -148.99% | -196.62% | -107.69% |
| Earnings before Tax (EBT) 1 | -17 | -21.53 | -26.81 | -43.81 | -47.59 |
| Net income 1 | -17 | -21.53 | -26.81 | -43.82 | -47.62 |
| Net margin | -364.52% | -571.02% | -191.94% | -198% | -110.45% |
| EPS 2 | -638.9 | -842.4 | -234.5 | -67.08 | -36.20 |
| Free Cash Flow | - | -11.03 | -15.41 | -26.64 | -31.22 |
| FCF margin | - | -292.49% | -110.33% | -120.36% | -72.42% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 10/9/20 | 10/9/20 | 3/31/21 | 3/29/22 | 4/14/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | 4.027 | 5.03 | 5.792 | 7.28 | 9.114 | 11.18 | 11.46 | 11.35 | - |
| EBITDA 1 | -8.85 | -9.722 | -10.13 | -10.92 | -11.77 | -10.32 | -9.31 | -8.724 | -4.127 |
| EBIT 1 | -9.651 | -10.46 | -11.02 | -12.37 | -12.77 | -11.42 | -11.49 | -10.74 | -10.74 |
| Operating Margin | -239.66% | -208.01% | -190.35% | -169.92% | -140.1% | -102.09% | -100.26% | -94.66% | - |
| Earnings before Tax (EBT) | -9.452 | -10.46 | -11.27 | -12.63 | -13.02 | -11.69 | -11.81 | -11.07 | - |
| Net income 1 | -9.452 | -10.46 | -11.27 | -12.63 | -13.02 | -11.72 | -11.81 | -11.07 | -17.33 |
| Net margin | -234.72% | -208.03% | -194.63% | -173.43% | -142.88% | -104.77% | -103.01% | -97.53% | - |
| EPS 2 | -14.50 | -16.00 | -17.00 | -19.00 | -20.00 | -8.500 | -7.500 | -7.000 | -3.000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 5/12/21 | 8/11/21 | 11/8/21 | 3/24/22 | 5/12/22 | 8/11/22 | 11/10/22 | 4/13/23 | 5/18/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net Debt 1 | 7.98 | 4.78 | - | - | - |
| Net Cash position 1 | - | - | 54.5 | 7.44 | 4.37 |
| Leverage (Debt/EBITDA) | -0.5453 x | -0.2505 x | - | - | - |
| Free Cash Flow | - | -11 | -15.4 | -26.6 | -31.2 |
| ROE (net income / shareholders' equity) | - | 426% | -92.6% | -109% | -239% |
| ROA (Net income/ Total Assets) | - | -84.1% | -29.8% | -50.6% | -81.4% |
| Assets 1 | - | 25.61 | 90.01 | 86.58 | 58.49 |
| Book Value Per Share 2 | -64.20 | -81.00 | 96.00 | 29.00 | 12.80 |
| Cash Flow per Share 2 | 3.200 | 7.360 | 91.00 | 29.90 | 7.050 |
| Capex 1 | 0.59 | 0.4 | 0.66 | 0.84 | 1.22 |
| Capex / Sales | 12.69% | 10.58% | 4.74% | 3.8% | 2.82% |
| Announcement Date | 10/9/20 | 10/9/20 | 3/31/21 | 3/29/22 | 4/14/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -100.00% | 322 | |
| +11.73% | 82.35B | |
| +20.17% | 71.09B | |
| +20.89% | 37.73B | |
| +15.77% | 32.01B | |
| +9.19% | 27.2B | |
| +3.18% | 26.74B | |
| +4.22% | 26B | |
| +16.93% | 25.5B | |
| +17.14% | 24.76B |
- Stock Market
- Equities
- MYOS Stock
- Financials MedAvail Holdings, Inc.
